Gempaz 25mg Tablet

Gempaz 25mg Tablet contains the active ingredient Empagliflozin. It belongs to a class of medications called sodium-glucose cotransporter 2 (SGLT2) inhibitors. Empagliflozin works by helping the kidneys remove glucose from the bloodstream through the urine, thereby lowering blood sugar levels in individuals with type 2 diabetes mellitus.

Uses:

• Type 2 diabetes mellitus: Gempaz 25mg Tablet is prescribed for the management of type 2 diabetes mellitus in adults. It helps improve glycemic control by reducing blood glucose levels through increased urinary glucose excretion.
• Blood sugar control: Empagliflozin helps lower fasting and postprandial blood sugar levels, thereby reducing the risk of hyperglycemia and diabetes-related complications.
• Cardiovascular protection: Empagliflozin has been shown to provide cardiovascular benefits by reducing the risk of cardiovascular events, such as heart attack, stroke, and cardiovascular death, in patients with type 2 diabetes mellitus and established cardiovascular disease.

Side Effects:

• Common side effects of Gempaz 25mg Tablet may include:
  • Genital yeast infections
  • Urinary tract infections
  • Increased urination
  • Thirst
  • Dizziness
  • Hypotension (low blood pressure)
• Serious but rare side effects may include ketoacidosis (high levels of ketones in the blood), hypoglycemia (low blood sugar), or allergic reactions. Contact your healthcare provider if you experience any severe or persistent side effects.

Precautions:

• Take Gempaz 25mg Tablet exactly as prescribed by your healthcare provider.
• Inform your doctor about any pre-existing medical conditions, especially kidney or liver disease, heart failure, or a history of diabetic ketoacidosis, before starting Empagliflozin therapy.
• Monitor your blood sugar levels regularly while taking Gempaz Tablet, and report any significant changes or episodes of hypoglycemia to your healthcare provider.
• Stay well-hydrated and maintain adequate fluid intake while on Empagliflozin therapy to reduce the risk of dehydration and related complications.

When Not to Use:

Avoid using Gempaz 25mg Tablet if:

• You have a known allergy to Empagliflozin or any other ingredients in the tablet.
• You have severe kidney impairment (eGFR less than 30 mL/min/1.73 m²) or end-stage renal disease (ESRD), as Empagliflozin may not be recommended in these patients.
• You are pregnant, planning to become pregnant, or breastfeeding without consulting your healthcare provider.